(Q47601659)

4 February 2018

title

Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. (English)

1 reference

4 February 2018

Markus Peck-Radosavljevic

0 references

1 reference

7

1 reference

4 February 2018

Franz König

object named as

Franz Koenig

3

0 references

author name string

Bernhard Angermayr

1

1 reference

4 February 2018

Manfred Cejna

2

1 reference

4 February 2018

Franz Karnel

4

1 reference

4 February 2018

Franz Hackl

5

1 reference

4 February 2018

Alfred Gangl

6

1 reference

4 February 2018

Vienna TIPS Study Group

8

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 February 2018

published in

Hepatology

1 reference

4 February 2018

volume

38

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

1043-1050

1 reference

4 February 2018

TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Variceal Bleeding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

The use and misuse of transjugular intrahepatic portasystemic shunts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

The North American Study for the Treatment of Refractory Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

ePTFE-Covered Stent-Grafts for Revision of Obstructed Transjugular Intrahepatic Portosystemic Shunt

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Primary implantation of polyester-covered stent-grafts for transjugular intrahepatic portosystemic stent shunts (TIPSS): A pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Prevention of rebleeding from oesophageal-gastric varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Stent-grafts for revision of TIPS stenoses and occlusions: a clinical pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Patency and reintervention rates during routine TIPSS surveillance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Natural history of portal hypertension in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Survival and prognostic indicators in compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Medical treatment of portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840380431

7 January 2021

Identifiers

DOI

10.1002/HEP.1840380431

1 reference

4 February 2018

PubMed ID

14512892

1 reference

4 February 2018